NCT04196673 (Acryvivi) is a NA clinical trial of Alcon SN60WF in Age Related Cataracts, sponsored by Medical University of Vienna.

Who is sponsoring NCT04196673?

NCT04196673 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04196673?

Interventions in NCT04196673: Alcon SN60WF, Hoya Vivinex.

What condition does NCT04196673 study?

NCT04196673 studies Age Related Cataracts.

Is NCT04196673 still recruiting?

NCT04196673 is currently completed. Last updated 12 December 2019.

Last reviewed 2019-12-12 · How we verify

NCT04196673: Acryvivi

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Posterior Capsule Opafication of Two Different Hydrophobic Acrylic Intraocular Lenses

Completed NA Last updated 12 December 2019

What this trial tests

NA trial testing Alcon SN60WF in Age Related Cataracts in 80 participants. Completed in 23 August 2019.

Timeline

1 September 2015

Primary endpoint
19 June 2016

23 August 2019

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	80
Start date	1 September 2015
Primary completion	19 June 2016
Estimated completion	23 August 2019

Drugs / interventions tested

Alcon SN60WF
Hoya Vivinex

Conditions studied

Age Related Cataracts — all drugs for Age Related Cataracts →

Sponsor

Medical University of Vienna

Who can join

Adults 50 to 100, any sex, with Age Related Cataracts. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

On the day of surgery, the first eye to be operated is randomised to receive a Vivinex , HOYA Surgical Optics GmbH or an SN60WF, Alcon, Fort Worth, Texas. The second eye to be operated receives the other IOL type. A complete biomicroscopic examination, visual acuity testing using autorefractometer, contrast sensitivity testing, and standardised retroillumination photography for PCO evaluation, will be performed 6 month (30-60 days), 1.5 years (± 3 months) and 3 (± 3 months) years postoperatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Age Related Cataracts

Currently open trials in the same condition.

NCT05822089 — Intraindividual Comparison of EMO IOLs · NA · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04196673 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 12 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04196673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing